Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Doxorubicin (Cytosafe)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Doxorubicin 10mg/5ml solution for injection Cytosafe vials
0801020K0BCAEAC
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 200mg/100ml inj Cytosafe vials
0801020K0BCAGAJ
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg/25ml solution for injection Cytosafe vials
0801020K0BCAFAD
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.